Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017 (HRB, Ireland)
Bibliography: Interventions – Treatment
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
Drug-Related Hospital Statistics Scotland 2017/18
This report describes the number of drug-related hospital stays, the number and characteristics of patients admitted to hospital, the substances involved and the geographical variations within Scotland (ISD)
Alcohol and other drug treatment services in Australia 2017–18: key findings
In 2017–18, 952 publicly-funded alcohol and other drug treatment services provided just under 210,000 treatment episodes to an estimated 130,000 clients. The four most common drugs that led clients to seek treatment were alcohol (34% of all treatment episodes), amphetamines (25%), cannabis (21%) and heroin (5%). Two-thirds (66%) of all clients receiving treatment were male and the median age of clients was 34 years (AIHW)
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017. The number of treated cases increased from 8,361 in 2011 to 9,892 in 2015, and then decreased to 8,922 in 2017
National Opioid Pharmacotherapy Statistics Annual Data collection (NOPSAD) 2018
On a snapshot day in 2018, just over 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,852 dosing points across Australia. There were 3,168 authorised prescribers of opioid pharmacotherapy drugs (AIHW)
Withdrawal Management Services in Canada: The National Treatment Indicators Report (PDF)
The report provides an overview of the use of WM services in Canada in 2015–2016, including episodes of care offered within specialized community-based services and in hospitals (CCSA)
Drug treatment systems in the Western Balkans: outcomes of a joint EMCDDA-UNODC survey of drug treatment facilities
This report presents a summary of the key findings from drug treatment facility surveys carried out in 2017 in Albania, Bosnia and Herzegovina, Serbia and the territory of Kosovo. The results provide insight into the characteristics and capacity of the treatment systems, as well as the availability and provision of treatment intervention (EMCDDA)
Survivors of Multiple Disadvantage Discuss Service & Support (PDF)
A report by Peer Researchers for the National Commission on Domestic and Sexual Violence and Multiple Disadvantage
Drug misuse in over 16s: opioid detoxification
2019 surveillance of drug misuse in over 16s: opioid detoxification (NICE guideline CG52)
Alcohol and drug treatment in secure settings: statistics summary 2017 to 2018
This National Drug Treatment Monitoring System (NDTMS) statistics report presents information on specialist treatment interventions for drugs and alcohol misuse in secure settings during 2017 to 2018 (public Health England)
Alcohol and drug misuse prevention and treatment guidance
Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions (PHE)
Examining the efficacy of the Building Skills for Recovery programme for substance misusing offenders in custody
A study looking at the efficacy of the Building Skills for Recovery (BSR) Programme for substance-misusing offenders in custody in England and Wales (Ministry of Justice)
Just Maintaining the Status Quo?
The experience of long-term participants in Methadone Maintenance Treatment – PDF (dun Laoghaire rathdown drug and alcohol Task force)
Substance misuse treatment for young people: statistics 2017 to 2018
Alcohol and drug treatment data for under-18s from PHE’s national drug treatment monitoring system (NDTMS)
Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States
Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member or close friend die from opioids. Increasing the availability and reducing the costs of approved medications for those with an opioid use disorder (OUD) is imperative; however, jurisdictions addressing OUDs and overdose may wish to consider additional interventions. Download (RAND)
Continuity of care for prisoners who need substance misuse treatment
An audit toolkit and guidance on data recording, for prison and community treatment providers and commissioners (Public Health England)
Guidance for drug and alcohol treatment providers and clients
Guidelines for drug and alcohol treatment providers on sharing client’s information with the National Drug and alcohol Treatment Monitoring System (NDTMS)
National Naloxone Programme Scotland Monitoring Report 2017/18 (PDF)
A total of 8,397 take-home naloxone kits were issued in Scotland in 2017/18, an increase of 3% from the previous year (NHS National Services Scotland)
Mental Health of Children and Young People in England, 2017
This survey series provides England’s best source of data on trends in child mental health. [Includes data on alcohol and drug use in the chapter on Behaviours, lifestyles and identities (NHS)
- 1
- 2
- 3
- …
- 11
- Next Page »
